Mubritinib
id:
mubritinib-248-14748741
title:
Mubritinib
text:
Mubritinib (TAK-165) is a protein kinase inhibitor which was under development by Takeda for the treatment of cancer. It completed phase I clinical trials but appears to have been discontinued, as no new information on the drug has surfaced since December 2008.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Mubritinib
date created:
date modified:
2023-04-01T23:12:02Z
main entity:
{"identifier":"Q6930896","url":"https://www.wikidata.org/entity/Q6930896"}
image:
fields total:
13
integrity:
14